» Articles » PMID: 20147899

Inflammation and Cancer: Causes and Consequences

Overview
Publisher Wiley
Specialty Pharmacology
Date 2010 Feb 12
PMID 20147899
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

The link between chronic inflammation and increased risk of developing some cancers is well established. The molecular mechanisms that underlie this process (cause) as well as the chronic inflammation that accompanies cancer (consequence) continue to be elucidated. Cancer-associated inflammation has effects on the ability of cancers to metastasize, on the clinical manifestations of cancer, and on the ability of the patient to tolerate anticancer therapy. The identification of biomarkers of cancer-associated inflammation will assist in identifying patients at risk of its consequences.

Citing Articles

Redox-Modulating Capacity and Effect of Ethyl Acetate Roots and Aerial Parts Extracts from L. on the Phenotype Inhibition of the Las/RhI Quorum Sensing System.

Dimitrova L, Mileva M, Georgieva A, Tzvetanova E, Popova M, Bankova V Plants (Basel). 2025; 14(2).

PMID: 39861566 PMC: 11768107. DOI: 10.3390/plants14020213.


Baseline [F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP.

Wen Z, Gao X, Wu Q, Yang J, Sun J, Wu K BMC Cancer. 2025; 25(1):128.

PMID: 39849387 PMC: 11756111. DOI: 10.1186/s12885-025-13507-3.


Utilizing machine learning algorithms for predicting risk factors for bone metastasis from right-sided colon carcinoma after complete mesocolic excision: a 10-year retrospective multicenter study.

Liu Y, Liu Y, Wang S, Niu S, Wang L, Xie J Discov Oncol. 2024; 15(1):463.

PMID: 39298052 PMC: 11413306. DOI: 10.1007/s12672-024-01327-z.


Integrative analysis reveals novel insights into juvenile idiopathic arthritis pathogenesis and shared molecular pathways with associated traits.

Pudjihartono N, Ho D, OSullivan J Front Genet. 2024; 15:1448363.

PMID: 39175752 PMC: 11338781. DOI: 10.3389/fgene.2024.1448363.


Low Expression MCEMP1 Promotes Lung Adenocarcinoma Progression and its Clinical Value.

Ling L, Hu T, Zhou C, Chen S, Chou L, Chen Y Curr Cancer Drug Targets. 2024; 25(3):281-293.

PMID: 38676531 DOI: 10.2174/0115680096292054240409070618.